MSB11022 in Healthy Subjects

NCT03014947 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

237

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: MSB11022
DRUG: US-licensed Humira
DRUG: EU-approved Humira

Sponsor

Fresenius Kabi SwissBioSim GmbH